Preparation and in vitro Evaluation of Linear and Star-branched PLGA Nanoparticles for Insulin Delivery

Abstract

Biodegradable nanoparticles, as drug delivery paradigms, have been extensively used for delivery of a wide range of small molecules as well as macromolecules, such as peptides, proteins, and genes. The morphological modification may improve the physicochemical characteristics of the biodegradable polymers. In the current investigation, the synthesis and characterization of linear, poly(D,L-lactide-co-glycolide) (PLGA)-poly(ethylene glycol) (PEG-PLGA), star-branched β-cyclodextrin-PLGA (β-CD-PLGA), and glucose-PLGA (Glu-PLGA) copolymers containing insulin as a model peptide drug have been reported. Linear and star-branched copolymers of PLGA were synthesized by bulk melt polymerization of the lactones (lactide and glycolide) in the presence of PEG, glucose, or β-CD using Sn-octoate as catalyst. Nanoparticles were prepared by a modified (w₁/o/w₂) double emulsion method. Bovine insulin was successfully encapsulated into the linear and star-branched PLGA nanoparticles with retention of insulin stability and the nanoparticles preparation process was optimized to reduce the burst effect and provide in vitro sustained release. The average particle size of samples was 120—355 nm. The cumulative amount of 65—84% insulin was released from the samples after 24 days. The yield of encapsulation of insulin was superior to 95%. Based on these findings, it is suggested that the novel PLGA nanoparticles can be used as a carrier for prolonged delivery of protein—peptide drugs.

Keywords

insulin nanomedicine peptide/protein delivery star-branched PLGA.

References

Daugherty, A.L. and Mrsny, R.J. (2003). Emerging Technologies that Overcome Biological Barriers for Therapeutic Protein Delivery, Expert Opin . Biol. Ther., 3(7): 1071—1081.

Woodley, J.F. (1994). Enzymatic Barriers for GI Peptide and Protein Delivery, Crit . Rev. Ther. Drug Carrier Syst., 11(2—3): 61—95.

van Hoogdalem, E.J. , de Boer, A.G. and Breimer, D.D. (1989). Intestinal Drug Absorption Enhancement: An Overview , Pharmacol. Ther., 44(3): 407—443.

Lambkin, I. and Pinilla, C. (2002). Targeting Approaches to Oral Drug Delivery, Expert Opin . Biol. Ther., 2(1): 67—73.

Fasano, A. (1998). Innovative Strategies for the Oral Delivery of Drugs and Peptides , Trends Biotechnol., 16(4): 152—157.

Batrakova, E.V. , Vinogradov, S.V. , Robinson , S.M. et al. (2005). Polypeptide Point Modifications with Fatty Acid and Amphiphilic Block Copolymers for Enhanced Brain Delivery, Bioconjug . Chem., 16(4): 793—802.

Torchilin, V.P. and Lukyanov, A.N. (2003). Peptide and Protein Drug Delivery to and into Tumors: Challenges and Solutions, Drug Discov . Today, 8(6): 259—266.

Lee, V.H. , Yamamoto, A. and Kompella, U.B. (1991). Mucosal Penetration Enhancers for Facilitation of Peptide and Protein Drug Absorption, Crit . Rev. Ther. Drug Carrier Syst., 8(2): 91—192.

Tozaki, H. , Emi, Y. , Horisaka, E. et al. (1997). Degradation of Insulin and Calcitonin and their Protection by Various Protease Inhibitors in Rat Caecal Contents: Implications in Peptide Delivery to the Colon , J. Pharm. Pharmacol., 49(2): 164—168.

10.

Mastrobattista, E. , Crommelin, D.J. , Wilschut , J. and Storm, G. (2002). Targeted Liposomes for Delivery of Protein-based Drugs into the Cytoplasm of Tumor Cells , J. Liposome Res., 12(1—2): 57—65.

11.

Lee, S.H. , Zhang, Z. and Feng, S.S. (2007). Nanoparticles of Poly(lactide)-tocopheryl Polyethylene Glycol Succinate (PLA-TPGS) Copolymers for Protein Drug Delivery , Biomaterials.

12.

Cui, F. , Shi, K. , Zhang, L. , Tao, A. and Kawashima, Y. (2006). Biodegradable Nanoparticles Loaded with Insulin-phospholipid Complex for Oral Delivery: Preparation, in vitro Characterization and in vivo Evaluation , J. Control Release, 114(2): 242—250.

13.

Lecaroz, C. , Gamazo, C. , Renedo, M.J. and Blanco-Prieto, M.J. (2006). Biodegradable Micro- and Nanoparticles as Long-term Delivery Vehicles for Gentamicin , J. Microencapsul., 23(7): 782—792.

14.

Panyam, J. and Labhasetwar, V. (2003). Biodegradable Nanoparticles for Drug and Gene Delivery to Cells and Tissue , Adv. Drug Deliv. Rev., 55(3): 329—347.

15.

Mesiha, M.S. , Sidhom, M.B. and Fasipe, B. (2005). Oral and Subcutaneous Absorption of Insulin Poly(isobutylcyanoacrylate) Nanoparticles , Int. J. Pharm., 288(2): 289—293.

16.

Jung, T. , Kamm, W. , Breitenbach, A. et al. (2000). Biodegradable Nanoparticles for Oral Delivery of Peptides: Is There a Role for Polymers to Affect Mucosal Uptake?, Eur . J. Pharm. Biopharm., 50(1): 147—160.

17.

Jain, R.A. (2000). The Manufacturing Techniques of Various Drug Loaded Biodegradable Poly(lactide-co-glycolide) (PLGA) Devices , Biomaterials, 21(23): 2475—2490.

18.

Dailey, L.A. , Wittmar, M. and Kissel, T. (2005). The Role of Branched Polyesters and their Modifications in the Development of Modern Drug Delivery Vehicles , J. Control Release, 101(1—3): 137—149.

19.

Breitenbach, A. , Li, Y.X. and Kissel, T. (2000). Branched Biodegradable Polyesters for Parenteral Drug Delivery Systems , J. Control Release, 64(1—3): 167—178.

20.

Davaran, S. , Rashidi, M.R. , Dadashzadeh , M. and Haghshenas, N.M. (2007). Adriamycin Release from Poly (lactide-co-glycolid)-Poly Ethylene Glycol Nanoparticles: Synthesis, and in vitro Characterization , Int. J. Nanomedicine (in press).

21.

Pistel, K.F. , Bittner, B. , Koll , H. , Winter, G. and Kissel, T. (1999). Biodegradable Recombinant Human Erythropoietin Loaded Microspheres Prepared from Linear and Star-branched Block Copolymers: Influence of Encapsulation Technique and Polymer Composition on Particle Characteristics , J. Control Release, 59(3): 309—325.

22.

Li, Y. , Nothnagel, J. and Kissel, T. (1997). Biodegradable Brush-like Polymers from Poly (DL-lactide) or Poly(D,L-lactide-co-glycolide) and Charged Modified, Hydrophilic Dextran Backbone — Synthesis , Characterization and in-vitro Degradation Properties, Polymer, 38: 6197—6206.

23.

Frauke, P.K. , Breitenbach, A. , Zange-Volland , R. and Kissel, T. (2001). Brush-like Branched Biodegradable Polyesters, Part III. Protein Release from Microspheres of Poly(vinyl Alcohol)-graft-poly(D,L-lactic-co-glycolic acid) , J. Control Release, 73(1): 7—20.

24.

Leobandung, W. , Ichikawa, H. , Fukumori , Y. and Peppas, N.A. (2002). Preparation of Stable Insulin-loaded Nanospheres of Poly(Ethylene Glycol) Macromers and N-isopropyl Acrylamide , J. Control Release, 80(1—3): 357—363.

25.

Irie, T. and Uekama, K. (1999). Cyclodextrins in Peptide and Protein Delivery , Adv. Drug Deliv. Rev., 36(1): 101—123.

26.

Jain, R.A. , Rhodes, C.T. , Railkar, A.M. , Malick, A.W. and Shah, N.H. (2000). Controlled Release of Drugs from Injectable in situ Formed Biodegradable PLGA Microspheres: Effect of Various Formulation Variables, Eur . J. Pharm. Biopharm., 50(2): 257—262.

27.

Avgoustakis, K. , Beletsi, A. , Panagi , Z. et al. (2003). Effect of Copolymer Composition on the Physicochemical Characteristics, in vitro Stability, and Biodistribution of PLGA-mPEG Nanoparticles , Int. J. Pharm. , 259(1—2): 115—127.

28.

Bezemer, J.M. , Radersma, R. , Grijpma , D.W. et al. (2000). Microspheres for Protein Delivery Prepared from Amphiphilic Multiblock Copolymers. 1. Influence of Preparation Techniques on Particle Characteristics and Protein Delivery , J. Control Release, 67(2—3): 233—248.

29.

Yeo, Y. and Park, K. (2004). Control of Encapsulation Efficiency and Initial Burst in Polymeric Microparticle Systems , Arch. Pharm. Res., 27(1): 1—12.

30.

Rizkalla, N. , Range, C. , Lacasse , F.X. and Hildgen, P. (2006). Effect of Various Formulation Parameters on the Properties of Polymeric Nanoparticles Prepared by Multiple Emulsion Method , J. Microencapsul., 23(1): 39—57.

31.

Pan, Y. , Zheng, J.M. , Zhao , H.Y. et al. (2002). Relationship between Drug Effects and Particle Size of Insulin-loaded Bioadhesive Microspheres , Acta Pharmacol. Sin., 23(11): 1051—1056.

32.

Mittal, G. , Sahana, D.K. , Bhardwaj, V. and Ravi Kumar, M.N. (2007). Estradiol Loaded PLGA Nanoparticles for Oral Administration: Effect of Polymer Molecular Weight and Copolymer Composition on Release Behavior in vitro and in vivo , J. Control Release.

33.

Li, Y. , Pei, Y. , Zhang, X. et al. (2001). PEGylated PLGA Nanoparticles as Protein Carriers: Synthesis, Preparation and Biodistribution in Rats , J. Control Release, 71(2): 203—211.

34.

Zhang, J.X. , Chen, D. , Wang , S.J. and Zhu , K.J. (2005). Optimizing Double Emulsion Process to Decrease the Burst Release of Protein from Biodegradable Polymer Microspheres , J. Microencapsul. , 22(4): 413—422.

35.

Chen, S. , Pieper, R. , Webster, D.C. and Singh, J. (2005). Triblock Copolymers: Synthesis, Characterization, and Delivery of a Model Protein , Int. J. Pharm., 288(2): 207—218.